Related Experiment Videos
Characterization of analgesic and activity effects of methotrimeprazine and morphine
Abstract:
The interactions of Methotrimeprazine (MTM) with the CNS opiate receptor, with naloxone, and with morphine were investigated. MTM (16--256 nM) did not compete with 3H-naloxone for specific binding sites in mouse brain homogenates. In vivo, MTM induced analgesia was not antagonized by naloxone. After 14 days administration of MTM partial tolerance developed to the activity effect but not the analgesic effect. After 14 days administration of morphine, tolerance developed to both the activity effect and the analgesic effect.
Insights
Methotrimeprazine (MTM) does not interact with CNS opiate receptors, as shown by naloxone binding assays and in vivo studies. MTM analgesia is not reversed by naloxone, and tolerance develops differently compared to morphine.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Methotrimeprazine (MTM) is an antipsychotic drug with potential analgesic properties.
- The central nervous system (CNS) opiate receptor system is crucial for pain modulation.
- Understanding MTM's interaction with the opiate system is essential for its clinical application.
Purpose of the Study:
- To investigate the interactions of Methotrimeprazine (MTM) with the CNS opiate receptor.
- To determine if MTM's analgesic effects are mediated through opiate pathways.
- To assess the development of tolerance to MTM's effects compared to morphine.
Main Methods:
- In vitro: Competition binding assays using 3H-naloxone and mouse brain homogenates.
- In vivo: Assessment of MTM-induced analgesia and activity effects.
- Antagonism studies using naloxone in MTM-treated animals.
- Chronic administration studies (14 days) to evaluate tolerance development.
Main Results:
- MTM did not compete with 3H-naloxone for specific binding sites in mouse brain homogenates.
- Naloxone did not antagonize MTM-induced analgesia in vivo.
- Partial tolerance to MTM's activity effect developed after 14 days, but not to its analgesic effect.
- Morphine induced tolerance to both activity and analgesic effects after 14 days.
Conclusions:
- MTM does not appear to interact directly with the CNS opiate receptor.
- MTM's analgesic effects are likely mediated through non-opiate pathways.
- Differential tolerance development suggests distinct mechanisms of action for MTM and morphine.